Exporting "failure": why research from rich countries may not benefit the developing world

Revista de Saúde Pública

J Jaime Miranda²  M Justin Zaman¹ 

[1] ,Universidad Peruana Cayetano Heredia Faculdad de Medicina Department of MedicineLima,Peru

关键词: Descriptors;    Biomedical Research;    trends;    Technical Cooperation;    Developed Countries;    Developing Countries;    Evidence-Based Medicine;    Pesquisa Biomédica;    tendências;    Cooperação Técnica;    Países Desenvolvidos;    Países em Desenvolvimento;    Medicina Baseada em Evidências;   

DOI  :  10.1590/S0034-89102010000100020

来源: SciELO

【 摘 要 】

The '10/90 gap' was first highlighted by the Global Forum for Health Research. It refers to the finding that 90% of worldwide medical research expenditure is targeted at problems affecting only 10% of the world's population. Applying research results from the rich world to the problems of the poor may be a tempting, potentially easy and convenient solution for this gap. This paper had the objective of presenting arguments that such an approach runs the risk of exporting failure. Health interventions that are shown to be effective in the specific context of a Western industrialized setting will not necessarily work in the developing world.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License